The Application of Patient-Derived Xenograft Models in Gynecologic Cancers
Authors:
Open Access
- 1 January 2020
- journal article
- review article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 11 (18) , 5478-5489
Abstract
Recently, due to the limitations of cell line models and animal models in the preclinical research with insufficient reflecting the physiological situation of humans, patient-derived xenograft (PDX) models of many cancers have been widely developed because of their better representation of the tumor heterogeneity and tumor microenvironment with retention of the cellular complexity, cytogenetics, and stromal architecture. PDX models now have been identified as a powerful tool for determining cancer characteristics, developing new treatment, and predicting drug efficacy. An increase in attempts to generate PDX models in gynecologic cancers has emerged in recent years to understand tumorigenesis. Hence, this review summarized the generation of PDX models and engraftment success of PDX models in gynecologic cancers. Furthermore, we illustrated the similarity between PDX model and original tumor, and described preclinical utilization of PDX models in gynecologic cancers. It would help supply better personalized therapy for gynecologic cancer patients.Keywords
This publication has 99 references indexed in Scilit:
- Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancerInternational Journal of Cancer, 2014
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapyProceedings of the National Academy of Sciences, 2014
- The Met receptor tyrosine kinase: A key player in oncogenesis and drug resistancePharmacology & Therapeutics, 2014
- An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancerGynecologic Oncology, 2014
- Patient-Derived Xenograft Models in Gynecologic MalignanciesAmerican Society of Clinical Oncology Educational Book, 2014
- Tumorgrafts as In Vivo Surrogates for Women with Ovarian CancerClinical Cancer Research, 2014
- Molecular correlates of platinum response in human high‐grade serous ovarian cancer patient‐derived xenograftsMolecular Oncology, 2014
- Continuing routine cardiac surveillance in long-term use of pegylated liposomal doxorubicin: Is it necessary?Gynecologic Oncology, 2013
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Establishment of human tumor xenografts in immunodeficient miceNature Protocols, 2007